Colitis ulcerative
Not recruitingStudy on Vedolizumab for Patients with Active Ulcerative Colitis
- Disease:Colitis ulcerative
- Substances:Vedolizumab
Poland- Participants:18–64 years · 65+ years
- Substances:Vedolizumab
- Sponsor:Alimentiv Inc.
Rare diseases
Investigational molecules
Locations
Back to Poland78 clinical trials in Sopot, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on inflammatory bowel diseases, particularly investigating novel therapies for both Crohn's Disease and Ulcerative Colitis. Multiple trials are evaluating new treatment approaches for patients with moderate to severe conditions.
Studies aim to improve clinical remission rates and enhance patient outcomes through innovative therapeutic approaches.
Leading investigations into cardiovascular diseases and conditions, with particular emphasis on heart failure and atherosclerotic cardiovascular disease. Studies include both preserved and reduced ejection fraction heart failure trials.
Research focuses on improving cardiovascular outcomes and developing new therapeutic strategies for heart disease management.
Groundbreaking research in Alzheimer's Disease treatment and management, including studies of early-stage interventions and cognitive decline prevention. Multiple trials are exploring novel therapeutic approaches.
Investigations focus on developing effective treatments for early-stage Alzheimer's and related cognitive conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.